Milrinone Lactate in Dextrose (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the Milrinone Lactate in Dextrose drug offered from Baxter Healthcare Corporation. This Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: MILRINONE LACTATE
SUBSTANCE NAME: MILRINONE LACTATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2002-05-28
END MARKETING DATE: 0000-00-00


Milrinone Lactate in Dextrose HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMilrinone Lactate in Dextrose from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 0.2(mg/mL)
START MARKETING DATE: 2002-05-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-6010_9ece85fc-d06c-40fb-a521-4c2690f03b86
PRODUCT NDC: 0338-6010
APPLICATION NUMBER: ANDA075834

Other MILRINONE LACTATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationMilrinone Lactate in Dextrose
Fresenius Kabi USA, LLCMilrinone Lactate
Gland Pharma LimitedMilrinone Lactate
Hospira, Inc.MILRINONE LACTATE
West-ward Pharmaceutical CorpMilrinone Lactate
West-ward Pharmaceutical Corp.Milrinone Lactate
West-Ward Pharmaceuticals CorpMilrinone Lactate in Dextrose